No Data
No Data
Changchun BCHT Biotechnology (SHSE:688276) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Investors were disappointed with Changchun BCHT Biotechnology Co.'s (SHSE:688276) earnings, despite the strong profit numbers. We think that the market might be paying attention to some underlying fa
Baike Biotech (688276): Shingles vaccine strongly drives growth, innovative vaccines open up future space
Incident: The company released its 2023 annual report, achieving operating income of 1,825 million yuan, +70.30% year-on-year; net profit to mother of 501 million yuan, +175.98% year-on-year; net profit of non-return to mother of 493 million yuan, same
Baike Biotech (688276): Blisters boost performance and expect continued growth
Incident The company released its 2023 annual report. In 2023, it achieved revenue of 1,825 billion yuan, a year-on-year increase of 70.30%; net profit to mother was 501 million yuan, an increase of 175.98%; net profit not attributable to mother4
Baike Biotech: Liquid nasal spray influenza vaccine products will soon apply for marketing approval
Glonghui, March 22 | Baike Biotech said on an interactive platform that the applicable age for clinical research on the company's liquid nasal spray influenza vaccine is 3-59 years old, and the product will soon apply for marketing approval.
Baike Biotech (688276): The contribution of shingles to elasticity continues to advance in the research pipeline
Investment highlights: Event: The company released its 2023 annual report. In 2023, the company achieved operating income of 1,825 million yuan (+70.30%) and realized net profit of 501 million yuan (+175.98%) to mother, achieved
Baig Biotech (688276): Performance is in line with expectations, rapid release of domestically produced shingles vaccine
Incident: The company disclosed its 2023 annual report, achieving revenue of 1,825 billion yuan, a year-on-year increase of 70.30%; net profit to mother of 501 million yuan, an increase of 175.98%; net profit of non-return to mother of 493 million yuan.
No Data